Results 251 to 260 of about 380,167 (333)
Optimizing Mycophenolate Therapy in Renal Transplant Patients Using Machine Learning and Population Pharmacokinetic Modeling. [PDF]
Tsyplakova A +3 more
europepmc +1 more source
The organ transplanted patient - immunological concepts and immunosuppression [PDF]
Husberg, BS, Klintmalm, GBG, Starzl, TE
core
Background Beyond its role as a ribosome‐targeting antibiotic, linezolid was recently shown to modulate immune responses by inhibiting mitochondrial translation. Since mitochondrial dysfunction is implicated in various fibrotic diseases, including systemic sclerosis (SSc), this study aimed to evaluate the antifibrotic potential of linezolid and ...
Xuezhi Hong +13 more
wiley +1 more source
Impact of cytochrome P450 3A5 expression on clinical outcomes in renal transplant recipients receiving tacrolimus-based immunosuppression. [PDF]
Pasari AS +15 more
europepmc +1 more source
Background Using hydroxychloroquine (HCQ) dose of 5 mg/kg/day in systemic lupus erythematosus (SLE) is associated with a higher risk of flares; HCQ blood level monitoring could be a better way to adjust HCQ dose. We studied the upper threshold for a reference range of HCQ levels to inform routine monitoring.
Shivani Garg +42 more
wiley +1 more source
Refining tacrolimus dosing through CYP3A5 pharmacogenetics in Taiwanese renal transplant recipients. [PDF]
Chang YL +7 more
europepmc +1 more source
Objective High intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced SSc. The role of reduced intensity conditioning (RIC) prior to AHSCT in this population remains unclear. We conducted this study to determine the long‐term outcomes of RIC AHSCT in SSc patients with cardiac ...
Yonatan Lean +4 more
wiley +1 more source
Blastomycosis in a Renal Transplant Recipient: A Rare Encounter in Rural Appalachia. [PDF]
Omar KO, Sebastian W, Kemper S.
europepmc +1 more source

